Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2476 participants.
Also called NCT03417388
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,476 participants
- Registry
-
NCT03417388
-
- Other papers using this trial's data
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR): a randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Puerto Rico
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03417388. Randomized; single masking; primary purpose treatment. Start 2018-02-09 (actual); primary completion 2025-02-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
- Acronym
- WARRIOR
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- High dose potent statin
- Intervention (Drug)
- ACE-I (lisinopril) or ARB (losartan)
- Intervention (Drug)
- Aspirin 81 enteric coated tablet daily
- Intervention (Behavioral)
- Lifestyle Counseling
- Intervention (Behavioral)
- Quality of Life Questionnaires
- Lead sponsor
- Cedars-Sinai Medical Center
- Collaborator
- United States Department of Defense
- Collaborator
- University of Florida
Record details
- Record id
cardio:ct-nct03417388- Content hash
deafbe2ae4072bebaf781a8a134152b72b0abb5794493de92616cf5658c54351